Publication Cover
Xenobiotica
the fate of foreign compounds in biological systems
Volume 30, 2000 - Issue 3
93
Views
23
CrossRef citations to date
0
Altmetric
Research Article

Metabolism and disposition of luminol in the rat

, , &
Pages 263-272 | Published online: 22 Sep 2008

References

  • ARNOLD, R., WERNER, F., HUMBERT, B., WERCHAU, H. and KONIG, W., 1994, Effect of respiratory syncytial virus-antibody complexes on cytokine (IL-8, IL-6, TNF-a) release and respiratory burst in human granulocytes. Immunology, 82, 184–191.
  • ASHBY, J. and TENNANT, R. W., 1991, Definitive relationships among chemical structure, carcinogenicity and mutagenicity for 301 chemicals tested by the U. S. NTP. Mutation Research, 257, 229–306.
  • BECKER, B. F., RASCHKE, P., BARDENHELJER, H. and GERLACH, E., 1993, Granulocytes, reactive oxygen species and uric acid. Pharmaceutical and Pharmacological Letters, 3, 93–96.
  • H1RAYAMA, O., TAGAGI, M., HUKLJMOTO, K. and KATOH, S., 1997, Evaluation of antioxidant activity by chemiuminescence. Analytical Biochemistry, 247, 237–241.
  • IKUSHIMA, T., 1990, Bimodal induction of sister-chromatid exchanges by luminol, an inhibitor of poly(ADP-ribose) synthetase, during the S-phase of the cell cycle. Chromosoma, 99, 360–364.
  • IRiE, S., 1960a, The treatment of alopecia areata with 3-aminophthalhydrazide. Current Therapeutic Research, 2, 107–110.
  • IRiE, S., 1960b, Observations on the diuretic effects of 3-aminophthalhydrazide. Current Therapeutic Research, 2, 132–136.
  • IRiE, S., 1960c, Influence of 3-aminophthalhydrazide on the prothrombin time. Current Therapeutic Research, 2, 153–157.
  • KRICKA, L. J., 1995, Chemiluninescence and bioluminescence. Analytical Chemistry, 67, 499R-502R. LILIENBLUM, W. and BOCK, K. W., 1984, N-glucuronide formation of carcinogenic aromatic amines in rat and human liver microsomes. Biochemical Pharmacology, 33, 2041–2046.
  • MAGUIRE, J. H., BUTLER, T. C. and DUDLEY, K. H., 1982,5-Ethy1-5-phenythydantoin N-glucuronide, the major urinary metabolite of 5-ethyl-5-phenythydantoin (Nirvanol) in the dog. Drug Metabolism and Disposition, 10, 595–598.
  • MARHOFFER, W., STEIN, M., SCHLEINKOFFR, L. and FEDERLIN, K., 1994, Monitoring of polymorpho-nuclear leukocyte functions in diabetes mellitus-A comparative study of conventional radiometric function tests and low-light imaging systems. Journal of Bioluminescence and Chemiluminescence, 9, 165–170.
  • ORZECHOWSKI, A., SCHRENK, D. and BOCK, K. W., 1992, Metabolism of 1- and 2-naphthylamine in isolated rat hepatocytes. Carcinogenesis, 13, 2227–2232.
  • REGEHR, M. F. and REGNIER, F. E., 1996, Chemiluminescent detection for capillary electrophoresis and EMMA enzyme assays. Journal of Capillary Electrophoresis, 3, 117–124.
  • RTECS, 1999, ONLINE . BIBLIOGRAPHIC DATABASE.
  • SAEZ, F., MOITA, C., BOUCHER, D. and GRIZARD, G., 1998, Antioxidant capacity of prostasomes in human semen. Molecular Human Reproduction, 4, 667–672.
  • SHEWRY, P. R. and Fro°, R. J., 1998, Protein blotting. In R. Rapley and J. M. Walker (eds), Molecular Biomethods Handbook (Totawa: Humana), pp. 435–444.
  • TSUJIUCHI, T., Tsuisumi, M., DENDA, A., KONDOH, S., NAKAE, D., MARUYAMA, H. and KONISHI, 1990, Possible involvement of poly ADP-ribosylation in phenobarbital promotion of rat hepatocarcinogenesis. Carcinogenesis, 11, 1783–1787.
  • YESHION, T. E., 1991, The forensic application of luminol as a presumptive blood test. In P. E. Stanley, P. E and L. J. Krika (eds), Chemiluminescence and Bioluminescence: Current Status (Chichester: Wiley), pp. 379–384.
  • ZEIGER, E., ANDERSON, B., HAWORTH, S., LAWLOR, T. and MORTELMANS, K., 1992, Salmonella mutagenicity tests: V. Results from the testing of 311 chemicals. Environmental Molecular Mutagenesis, 19, 2–141.
  • ZENSER, T. V., LAKsiimi, V. M. and DAWS, B. B., 1998,1996 ASPET N-glucuronidation of xenobiotics symposium. N-glucuronidation of benzidine and its metabolites. Role in bladder cancer. Drug Metabolism and Disposition, 26, 856–859.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.